Chronic heart failure-induced skeletal muscle atrophy, necrosis, and changes in myogenic regulatiory factors

Medical Science Monitor

Volumn 16, Issue 12, 2010, Pages

  Martinez, Paula F ^a   Okoshi, Katashi ^a   Zornoff, Leonardo A M ^a   Carvalho, Robson F ^a   Oliveira Jr , Silvio A ^a,b   Lima, Aline R R ^a   Campos, Dijon H S ^a   Damatto, Ricardo L ^a   Padovani, Carlos R ^a,b   Nogueira, Celia R ^a   Pai Silva, Maeli D ^a   Okoshi, Marina P ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Cytokines; Myocardial infarction; Myogenic regulatory factors; Myosin heavy chain

Indexed keywords

INTERLEUKIN 6; MYOGENIC FACTOR; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEIN MRF4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MESSENGER RNA; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 4; MYOSIN HEAVY CHAIN I; MYOSIN HEAVY CHAIN IIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; MALE; MUSCLE ATROPHY; NECROSIS; NONHUMAN; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; ANIMAL TISSUE; CELL TYPE; GENE EXPRESSION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE SIZE; HISTOPATHOLOGY; INFLAMMATORY CELL; MUSCLE CELL; MUSCLE NECROSIS; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 79951562366     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mancini DM, Walter G, Reichek N et al: Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation, 1992; 85: 1364-73
2. Harrington D, Anker SD, Coats AJS: Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J, 2001; 22: 392-99
3. Vescovo G, Ceconi C, Bernocchi P et al: Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovasc Res, 1998; 39: 233-41
4. Strassburg S, Springer J, Anker SD: Muscle wasting in cardiac cachexia. Intern J Biochem Cell Biol, 2005; 37(10): 1938-47
5. Harrington D, Anker SD, Chua TP et al: Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol, 1997; 30: 1758-64
6. Smith CK, Janney MJ, Allen RE: Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physiol, 1994; 159(2): 379-85
7. Megeney LA, Rudnicki MA: Determination versus differentiation and the MyoD family of transcription factors. Biochem Cell Biol, 1995; 73: 723-32
8. Seward DJ, Haney JC, Rudnick MA, Swoap SJ: bHLH transcription factor MyoD affects pattern in a muscle-specific fashion. Am J Physiol Cell Physiol, 2001; 85: C408-13
9. Koller A, Haid C: Is restoring regenerative potential a way to prevent anthracycline cardiotoxicity? A hypothesis. Med Sci Monit, 2005; 11(7): HY21-23
10. Hughes SM, Chi MM-Y, Lowry OH, Gundersen K: Myogenin induces a shift of enzyme activity from glycolytic to oxidative metabolism in muscles of transgenic mice. J Cell Biol, 1999; 145(3): 633-42
11. Loughna PT, Brownson C: Two myogenic regulatory factor transcripts exhibit muscle-specific responses to disuse and passive stretch in adult rats. FEBS Letter, 1996; 390: 304-6
12. Hughes SM, Taylor JM, Tapscott SJ et al: Selective accumulation of MyoD and myogenin mRNAs in fast and slow muscle is controlled by innervation and hormones. Development, 1993; 118: 1137-47
13. Langen RCJ, Schols AMWJ, Kelders MCJM et al: Tumor necrosis factoralpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol, 2002; 283: C714-21
14. Langen RCJ, van der Velden JLJ, Schols AMWJ et al: Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J, 2004; 18: 227-37
15. Carvalho RF, Cicogna AC, Campos GER et al: Heart failure alters MyoD and MRF4 expressions in rat skeletal muscle. Int J Exp Path, 2006; 87: 219-25
16. Zornoff LAM, Matsubara BB, Matsubara LS et al: Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats. Basic Res Cardiol, 2000; 95: 208-14
17. Cicogna AC, Robinson KG, Conrad CH et al: Direct effects of colchicines on myocardial function. Studies in hypertrophied and failing spontaneously hypertensive rats. Hypertension, 1999; 33: 60-65
18. Bing OHL, Brooks WW, Robinson KG et al: The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol, 1995; 27: 383-96
19. Okoshi K, Matsubara LS, Okoshi MP et al: Food restriction-induced myocardial dysfunction demonstrated by the combination of in vivo and in vitro studies. Nutr Res, 2002; 22: 1353-64
20. Paiva SAR, Zornoff LAM, Okoshi MP et al: Ventricular remodeling induced by retinoic acid supplementation in adult rats. Am J Physiol Heart Circ Physiol, 2003; 284: H2242-46
21. Lang RM, Bierig M, Devereux RB et al: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr, 2005; 18: 1440-63
22. Solomon SD, Greaves SC, Ryan M et al: Temporal dissociation of left ventricular function and remodeling following experimental myocardial infarction in rats. J Card Fail, 1999; 5: 213-23
23. Minicucci MF, Azevedo PS, Duarte DR et al: Comparison of different methods to measure experimenal chronic infarction size in the rat model. Arq Bras Cardiol, 2007; 89(2): 83-87
24. Oh B-H, Ono S, Rockman HR, Ross J: Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion. Circulation, 1993; 87: 598-607
25. Brooke MH, Kaiser KK: Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulphydryl dependence. J Histochem Cytochem, 1970; 18: 670-72
26. Lopes FS, Carvalho RF, Campos GER et al: Down-regulation of MyoD gene expression in rat diaphragm muscle with heart failure. Int J Exp Path, 2008; 89: 216-22
27. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001; 25(4): 402-8
28. Dasarathy S, Muc S, Hisamuddin K et al: Altered expression of genes regulating skeletal muscle mass in the portcaval anastomosis rat. Am J Physiol Gastrointest Liver Physiol, 2007; 292: G1105-13
29. Broderick TL, King TM: Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension. Med Sci Monit, 2008; 14(12): BR261-64
30. Sato H, Kasai K, Tanaka T et al: Role of tumor necrosis factor-alpha and interleukin-1beta on lung dysfunction following hemorrhagic shock in rats. Med Sci Monit, 2008; 14(5): BR79-87
31. Sjaastad I, Sejersted OM, Ilebekk A, Bjornerheim R: Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl Physiol, 2000; 89: 1445-54
32. Carvalho RF, Dariolli R, L.A. JJ, Sugizaki MM et al: Heart failure alters matrix metalloproteinase gene expression and activity in rat skeletal muscle. Int J Exp Pathol, 2006; 87: 437-43
33. Carvalho RF, Cicogna AC, Campos GER et al: Myosin heavy chain expression and atrophy in rat skeletal muscle during transition from cardiac hypertrophy to heart failure. Int J Exp Path, 2003; 84: 201-6
34. De Sousa E, Veksler V, Bigard X et al: Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation, 2000; 102: 1847-53
35. Vescovo G, Volterrani M, Zennaro R et al: Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart, 2000; 84: 431-37
36. Dalla Libera L, Zennaro R, Sandri M et al: Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol Cell Physiol, 1999; 277: C982-86
37. Burniston JG, Saini A, Tan L-B, Goldspink DF: Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol, 2005; 39: 395-99
38. Dalla Libera L, Sabbadini R, Renken C et al: Apoptosis in the skeletal muscle of rats with heart failure is associated with incresead serum levels of TNF-a and sphingosine. J Mol Cell Cardiol, 2001; 33: 1871-78
39. Toth MJ, Ades PA, LeWinter MM et al: Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J Appl Physiol, 2006; 100: 35-41
40. Toth MJ, Ades PA, Tischler MD et al: Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol, 2006; 109(2): 179-87
41. Ng YL, Goldspink DF, Burniston JG et al: Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle. Int J Cardiol, 2002; 86: 299-309
42. Santos DP, Okoshi K, Moreira VO et al: Growth hormone attenuates skeletal muscle changes in experimental chronic heart failure. Growth Horm IGF Res, 2010; 20: 149-55
43. Dalla Libera L, Ravara B, Angelini A et al: Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. Circulation, 2001; 103: 2195-200
44. Spangenburg EE, Talmadge RJ, Musch TI et al: Changes in skeletal muscle myosin heavy chain isoform content during congestive heart failure. Eur J Appl Physiol, 2002; 87: 182-86
45. Langen RCJ, Schols AMWJ, Kelders MCJM et al: Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factorkappaB. FASEB J, 2001; 15: 1169-80